Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol + hydrochlorothiazide versus irbesartan + hydrochlorothiazide in elderly patients with isolated systolic hypertension
2010-023104-28Phase 4Completed
- Sponsor
- Menarini Group
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in isolated systolic hypertension (ISH) comparing Nebivolol + hydrochlorothiazide with Irbesartan + hydrochlorothiazide (2 arms). Primary endpoint: Change in systolic blood pressure. Started Jun 2011; status: completed.
02
Drugs
nebivololirbesartanhydrochlorothiazide
03
Conditions
isolated systolic hypertension (ISH)
Beyond the preview
Go deeper on 2010-023104-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023104-28.